TruDataRx
PrivateLast Round
Angel
May 15, 2017
Total Funding Raised
$275,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TruDataRx is a healthcare data analytics company that provides comparative effectiveness research and evidence-based algorithms to help self-insured employers and plan sponsors optimize pharmacy benefit management and reduce drug spending.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Business Intelligence, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TruDataRx Comparables
Compare TruDataRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ARMSRx | 78% | |
| EmpiRx Health | 78% | |
| Truveris | 77% |
TruDataRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | May 15, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 211% MoM, reaching 4.1K.
- Jan 26, 2026
Monthly visitors increased 133% MoM, reaching 2.8K.
TruDataRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TruDataRx's valuation, stock price, and market status.
Is TruDataRx a public or private company?
TruDataRx is a private company.
What is the current stock price of TruDataRx?
TruDataRx is a private company with no public stock price. No recent secondary market data is available.
How much is TruDataRx worth (valuation)?
Valuation information for TruDataRx is not publicly available.
Can I buy TruDataRx stock?
TruDataRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TruDataRx's last funding round?
TruDataRx's most recent funding round was Angel on May 15, 2017.
Who are the main investors in TruDataRx?
Investor information for TruDataRx is not publicly disclosed.
Will TruDataRx IPO soon?
No public IPO plans have been announced for TruDataRx.
How can I track TruDataRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TruDataRx's secondary market activity and sign up for updates.